HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Ye Selected Research

Ran binding protein 9

1/2017Reduced Expression of RanBPM Is Associated with Poorer Survival from Lung Cancer and Increased Proliferation and Invasion of Lung Cancer Cells In Vitro.
3/2016Reduced RanBPM Expression Is Associated with Distant Metastasis in Gastric Cancer and Chemoresistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Ye Research Topics

Disease

117Neoplasms (Cancer)
11/2022 - 02/2007
49Neoplasm Metastasis (Metastasis)
11/2022 - 02/2007
34Breast Neoplasms (Breast Cancer)
01/2022 - 08/2003
29Prostatic Neoplasms (Prostate Cancer)
01/2021 - 02/2007
22Inflammation (Inflammations)
03/2022 - 05/2015
15Lung Neoplasms (Lung Cancer)
01/2021 - 09/2008
12Stomach Neoplasms (Stomach Cancer)
11/2022 - 11/2012
11Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 01/2010
11Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2009
10Carcinogenesis
11/2022 - 10/2010
10Carcinoma (Carcinomatosis)
01/2022 - 04/2010
9Pancreatic Neoplasms (Pancreatic Cancer)
06/2021 - 03/2016
8Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 01/2013
8Body Weight (Weight, Body)
01/2022 - 07/2014
8Wounds and Injuries (Trauma)
05/2021 - 11/2010
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2020 - 09/2008
7Obesity
01/2022 - 08/2011
6Fibrosis (Cirrhosis)
06/2022 - 12/2015
6Disease Progression
06/2021 - 01/2017
6Hepatocellular Carcinoma (Hepatoma)
03/2021 - 04/2012
6Infections
01/2020 - 07/2014
5Non-alcoholic Fatty Liver Disease
06/2022 - 06/2016
5COVID-19
11/2021 - 11/2020
5Diabetic Nephropathies (Diabetic Nephropathy)
05/2021 - 10/2019
5Esophageal Squamous Cell Carcinoma
04/2021 - 01/2014
4Adenocarcinoma
01/2022 - 12/2012
4Hypoxia (Hypoxemia)
05/2021 - 04/2014
4Stroke (Strokes)
01/2021 - 03/2011
4Necrosis
01/2021 - 07/2009
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 01/2017
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2017 - 12/2011
3Hyperplasia
05/2022 - 04/2016
3Osteoporosis
01/2022 - 10/2021
3Melanoma (Melanoma, Malignant)
01/2022 - 08/2013
3Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2022 - 03/2015
3Osteosarcoma (Osteogenic Sarcoma)
11/2021 - 09/2013
3Colonic Neoplasms (Colon Cancer)
11/2021 - 01/2010
3Lipid Metabolism Disorders (Metabolism Disorders, Lipid)
10/2021 - 06/2019
3Neuroblastoma
09/2021 - 01/2018
3Ischemia
01/2021 - 10/2013
3Aneurysm (Aneurysms)
01/2021 - 04/2013
3Ischemic Stroke
01/2021 - 03/2011
3Nausea
12/2020 - 09/2015
3Vomiting
12/2020 - 09/2015
3Adenocarcinoma of Lung
05/2020 - 01/2018
3Weight Gain
02/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

80Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2005
29Biological ProductsIBA
01/2022 - 09/2008
28Messenger RNA (mRNA)IBA
01/2022 - 01/2005
20Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2020 - 02/2007
17CytokinesIBA
06/2022 - 06/2004
17Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2013
12LipidsIBA
06/2022 - 01/2016
12MicroRNAs (MicroRNA)IBA
03/2022 - 02/2013
12Diethylhexyl Phthalate (DEHP)IBA
01/2022 - 07/2014
10Catalytic RNA (Ribozymes)IBA
05/2017 - 09/2007
8Pharmaceutical PreparationsIBA
01/2022 - 07/2008
8Growth InhibitorsIBA
01/2017 - 07/2009
7EnzymesIBA
12/2021 - 06/2004
7Long Noncoding RNAIBA
03/2021 - 01/2018
7Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2015 - 02/2007
6RNA (Ribonucleic Acid)IBA
01/2022 - 07/2020
6Small Interfering RNA (siRNA)IBA
01/2022 - 03/2009
6Glucose (Dextrose)FDA LinkGeneric
01/2021 - 05/2015
6LigandsIBA
01/2021 - 07/2009
6Cisplatin (Platino)FDA LinkGeneric
01/2021 - 09/2018
6S100 Calcium Binding Protein A7IBA
01/2020 - 12/2012
6yangzheng xiaojiIBA
09/2015 - 07/2012
5phthalic acid (phthalate)IBA
05/2022 - 04/2019
5ImmunosorbentsIBA
12/2021 - 06/2004
5Therapeutic UsesIBA
10/2021 - 11/2005
5Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2021 - 01/2005
5CateninsIBA
10/2020 - 06/2017
5Fluorouracil (Carac)FDA LinkGeneric
10/2020 - 01/2009
4Indicators and Reagents (Reagents)IBA
01/2022 - 11/2010
4CollagenIBA
01/2022 - 05/2015
4Blood Glucose (Blood Sugar)IBA
01/2021 - 01/2017
4Transforming Growth Factors (Transforming Growth Factor)IBA
11/2020 - 10/2012
4AutoantibodiesIBA
01/2020 - 07/2010
4Bone Morphogenetic Protein ReceptorsIBA
01/2020 - 02/2007
4Protein Isoforms (Isoforms)IBA
05/2017 - 01/2011
4Epidermal Growth Factor (EGF)IBA
03/2017 - 01/2009
4hammerhead ribozymeIBA
03/2016 - 07/2008
4Growth Differentiation Factor 9IBA
03/2012 - 11/2010
3Phosphotransferases (Kinase)IBA
11/2022 - 02/2018
3mono-(2-ethylhexyl)phthalateIBA
05/2022 - 11/2019
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2021 - 06/2004
3CurcuminIBA
11/2021 - 01/2021
3Transforming Growth Factor beta (TGF-beta)IBA
01/2021 - 10/2012
3Matrix Metalloproteinases (MMPs)IBA
06/2019 - 09/2014
3AntigensIBA
05/2019 - 01/2011
3Peptides (Polypeptides)IBA
01/2019 - 10/2013

Therapy/Procedure

26Therapeutics
01/2022 - 07/2008
11Drug Therapy (Chemotherapy)
01/2022 - 02/2010
4Radiotherapy
01/2022 - 12/2013
4Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 03/2015
4Prostatectomy (Retropubic Prostatectomy)
01/2021 - 06/2014
3Immunotherapy
01/2022 - 05/2021
3Craniotomy
12/2020 - 01/2020
3Enhanced Recovery After Surgery
12/2020 - 01/2020